KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Tenet Healthcare (THC) over the last 17 years, with Q4 2025 value amounting to $2.9 billion.

  • Tenet Healthcare's Cash & Equivalents fell 450.48% to $2.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 billion, marking a year-over-year decrease of 450.48%. This contributed to the annual value of $2.9 billion for FY2025, which is 450.48% down from last year.
  • According to the latest figures from Q4 2025, Tenet Healthcare's Cash & Equivalents is $2.9 billion, which was down 450.48% from $3.0 billion recorded in Q3 2025.
  • Over the past 5 years, Tenet Healthcare's Cash & Equivalents peaked at $4.1 billion during Q3 2024, and registered a low of $766.0 million during Q1 2023.
  • Moreover, its 5-year median value for Cash & Equivalents was $2.2 billion (2021), whereas its average is $2.1 billion.
  • Per our database at Business Quant, Tenet Healthcare's Cash & Equivalents crashed by 6370.56% in 2022 and then surged by 28842.5% in 2024.
  • Quarter analysis of 5 years shows Tenet Healthcare's Cash & Equivalents stood at $2.4 billion in 2021, then crashed by 63.71% to $858.0 million in 2022, then soared by 43.12% to $1.2 billion in 2023, then surged by 145.85% to $3.0 billion in 2024, then fell by 4.5% to $2.9 billion in 2025.
  • Its Cash & Equivalents stands at $2.9 billion for Q4 2025, versus $3.0 billion for Q3 2025 and $2.6 billion for Q2 2025.